Decreased PR expression in prostate tumors may result in relatively high levels of SDF-1 and IL-6 secreted by stromal cells, consistent with the reports that SDF-1 and IL-6 levels are elevated in cancer tissue samples [18], [19]. This evidence concerns the gene CXCL12 and cancer.